U.S. markets open in 6 hours 31 minutes
  • S&P Futures

    4,245.75
    +9.50 (+0.22%)
     
  • Dow Futures

    33,948.00
    +113.00 (+0.33%)
     
  • Nasdaq Futures

    14,297.00
    +38.75 (+0.27%)
     
  • Russell 2000 Futures

    2,299.80
    +7.30 (+0.32%)
     
  • Crude Oil

    73.08
    +0.02 (+0.03%)
     
  • Gold

    1,782.20
    +4.80 (+0.27%)
     
  • Silver

    25.97
    +0.11 (+0.44%)
     
  • EUR/USD

    1.1930
    -0.0013 (-0.11%)
     
  • 10-Yr Bond

    1.4720
    0.0000 (0.00%)
     
  • Vix

    16.66
    -1.23 (-6.88%)
     
  • GBP/USD

    1.3963
    +0.0016 (+0.11%)
     
  • USD/JPY

    110.8330
    +0.1980 (+0.18%)
     
  • BTC-USD

    33,924.66
    +1,195.45 (+3.65%)
     
  • CMC Crypto 200

    814.13
    +19.80 (+2.49%)
     
  • FTSE 100

    7,090.01
    +27.72 (+0.39%)
     
  • Nikkei 225

    28,874.89
    -9.24 (-0.03%)
     

Annovis Bio, Inc. (NYSEMKT:ANVS) Insiders Increased Their Holdings

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we'll take a look at whether insiders have been buying or selling shares in Annovis Bio, Inc. (NYSEMKT:ANVS).

What Is Insider Selling?

Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock in the company. However, most countries require that the company discloses such transactions to the market.

We don't think shareholders should simply follow insider transactions. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'.

View our latest analysis for Annovis Bio

The Last 12 Months Of Insider Transactions At Annovis Bio

Over the last year, we can see that the biggest insider purchase was by Independent Chairman of the Board Michael M. Hoffman for US$200k worth of shares, at about US$6.00 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$5.07). It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.

Annovis Bio insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Annovis Bio insiders own about US$13m worth of shares. That equates to 37% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Annovis Bio Tell Us?

It doesn't really mean much that no insider has traded Annovis Bio shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. Insiders own shares in Annovis Bio and we see no evidence to suggest they are worried about the future. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For example, Annovis Bio has 4 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.